Skip to content
Screener

DexCom DXCM Q2 2026 earnings

Reported July 30, 2026 · After market close

Revenue$1.3BBeat by $18.1M
Adjusted EPS$0.70Beat by $0.09
Revenue estimate$1.3B
EPS estimate$0.61
“This quarter's performance and the successful outcomes from our CONNECT trial reinforce our confidence in the path ahead and position us well to deliver on our long-range plan.”
Jake Leach

Earnings data and commentary were extracted with AI from company filings and may contain errors. Verify important details in the filing.

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.3B
EPS estimate$0.66

Financials

Q2 2026

Income statement

See full
Revenue$1.3B+13.1%
Gross profit$830.0M+20.5%
Operating income$318.3M+49.7%
Net income$249.1M+38.5%
EPS (diluted)$0.64+42.2%

Balance sheet

See full
Cash & equivalents$1.1B-4.8%
Total debt$103.3M-23.1%
Total equity$2.6B+1.9%
Total assets$6.5B-11.9%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$33.57B+12.1%
Enterprise value$32.57B+12.6%
P/E33.6×-18.8×
P/S6.8×-0.2×

Profitability

See full
Gross margin62.5%+3.7pp
Operating margin22.9%+6.9pp
Net margin20.1%+6.8pp

Returns & leverage

See full
Return on equity38.5%+15.7pp
Debt / equity0×0.0×
Current ratio1.7×+0.2×

FAQ

When did DexCom report Q2 2026 earnings?
DexCom (DXCM) reported Q2 2026 earnings on July 30, 2026 after market close.
What were DexCom's Q2 2026 revenue and EPS?
DexCom reported revenue of $1.3B and adjusted eps of $0.70 for Q2 2026.
Did DexCom beat estimates in Q2 2026?
Revenue beat the consensus estimate of $1.3B by $18.1M. EPS beat the consensus estimate of $0.61 by $0.09.
How did DexCom's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.1% from $1.2B a year earlier.
Where can I find DexCom's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001093557-26-000142) and the 10-Q periodic report (0001093557-26-000143) directly on SEC EDGAR. The filing index links above go to sec.gov.